What ACHILLION PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Truitt Joseph | Chief Executive Officer | Jan 28 | Disposition to Issuer · D | −3,500 | $6.30 | −$22.1K | 0 |
| G1 Execution SERVICES, Llc | 10% owner | Jan 28 | Other Transaction · J | −14,115,498 | $6.30 | −$88.9M | 0 |
| G1 Execution SERVICES, Llc | 10% owner | Jan 28 | Other Transaction · J | −10,917 | $6.30 | −$68.8K | 0 |
| Vitullo Nicole | Director | Jan 28 | Disposition to Issuer · D | −25,159 | $6.30 | −$159K | 0 |
| Vitullo Nicole | Director | Jan 28 | Disposition to Issuer · D | −3,393,382 | $6.30 | −$21.4M | 0 |
| Vitullo Nicole | Director | Jan 28 | Disposition to Issuer · D | −36,431 | $6.30 | −$230K | 0 |
| Fisherman Jason S | Director | Jan 28 | Disposition to Issuer · D | −1,500 | $6.30 | −$9.45K | 0 |
| Fisherman Jason S | Director | Jan 28 | Disposition to Issuer · D | −90,000 | $6.30 | −$567K | 0 |
| Graves Kurt | Director | Jan 28 | Disposition to Issuer · D | −22,709 | $6.30 | −$143K | 0 |
| Manning Martha E | General Counsel | Jan 28 | Disposition to Issuer · D | −2,500 | $6.30 | −$15.8K | 0 |
| Van Nostrand Robert L | Director | Jan 28 | Disposition to Issuer · D | −40,000 | $6.30 | −$252K | 0 |
| Scheer David | Director | Jan 28 | Disposition to Issuer · D | −63,249 | $6.30 | −$398K | 0 |
| Scheer David | Director | Jan 28 | Disposition to Issuer · D | −29,515 | $6.30 | −$186K | 0 |
| Van Nostrand Robert L | Director | Dec 18 | Exercise / conversion · M | +20,000 | $3.28 | +$65.6K | 40,000 |
| Fisherman Jason S | Director | Nov 14 | Exercise / conversion · M | +20,000 | $3.28 | +$65.6K | 90,000 |
| Scheer David | Director | Nov 13 | Open-market sale · S | −10,485 | $6.31 | −$66.2K | 29,515 |
| Scheer David | Director | Nov 13 | Exercise / conversion · M | +20,000 | $3.28 | +$65.6K | 40,000 |
| Truitt Joseph | Chief Executive Officer | Oct 16 | Open-market sale · S | −33,250 | $6.37 | −$212K | 3,500 |
| Truitt Joseph | Chief Executive Officer | Oct 16 | Open-market sale · S | −100,234 | $6.37 | −$639K | 36,750 |
| Truitt Joseph | Chief Executive Officer | Oct 16 | Exercise / conversion · M | +33,250 | $3.28 | +$109K | 136,984 |
Loading...
